|

SD-101 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: nelitolimod

Pipeline

Phase 1: 1

Top Sponsors

  • University of California, San Diego1

Indications

  • Liver Disease1
  • Liver Cancer1
  • Hepatocellular Carcinoma1
  • Cancer1

San Diego, California1 trial

Cryoablation and Arterial Infusion of SD-101 in Combination with Durvalumab and Tremelimumab

University of California, San Diego

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.